相关实验视频

Updated: Jul 18, 2025

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

在囊性纤维化新生儿查诊断和沟通挑战

Joan Kathleen DeCelie-Germana¹, Lynn Bonitz¹, Elinor Langfelder-Schwind²

¹Cohen Children's Medical Center, Division of Pediatric Pulmonary and Cystic Fibrosis, Zucker School of Medicine at Hofstra/Northwell, New York, NY 11040, USA.

Life (Basel, Switzerland)

|August 26, 2023

概括

囊性纤维化 (CF) 新生儿查 (NBS) 使用免疫反应性试素 (IRT),现在包括CFTR测序. 这有助于早期检测和公平识别患有CF的婴儿,提高长期结果.

科学领域:

遗传学是一个遗传学.
儿科儿科儿科
公共卫生公共卫生

背景情况:

囊性纤维化 (CF) 新生儿查 (NBS) 是美国的普遍公共卫生倡议.
免疫反应性试素 (IRT) 是主要的生物标志物,但有局限性.
实施CF NBS存在持续的挑战.

研究的目的:

审查CF NBS算法的演变情况.
讨论CF NBS中偏差减少的挑战和策略.
为未来的CF NBS计划提供建议.

主要方法:

审查纽约州CF NBS计划的演变.
对将CFTR测序纳入NBS算法进行分析.
对生物标志物性能和诊断挑战的检查.

主要成果:

CFTR测序增强了CF婴儿的早期识别.
基因检测提高了跨多元种群的公平鉴定.
不确的诊断在先进的查中是一个越来越大的挑战.

结论:

随着基因的进步,CF NBS已经显著发展.
解决CFNBS的挑战对于婴儿的最佳结果至关重要.
未来的NBS战略应侧重于公平性和诊断清晰度.

关键词:

结核病诊断挑战结核病诊断挑战在此之前,IRT是IRT.囊性纤维化症是什么民族多样性民族多样性新生儿屏幕新生儿屏幕

更多相关视频

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...